Scilex Holding (SCLX) Other Non-Current Assets (2020)

Scilex Holding (SCLX) recorded quarterly Other Non-Current Assets of $168973.0 in Q4 2020.

Scilex Holding (SCLX) Other Non-Current Assets (2020) Analysis & Trends

Scilex Holding's Other Non-Current Assets history runs 1 years deep, the most recent figure standing at $168973.0 for Q4 2020.

In Q4 2020, Other Non-Current Assets changed N/A year-over-year to $168973.0; the TTM figure through Dec 2020 stood at $168973.0 (changed N/A YoY), while the FY2020 annual figure was $168973.0, changed N/A from the prior year.
Other Non-Current Assets was $168973.0 for Q4 2020 at Scilex Holding.
In the past five years, Other Non-Current Assets ranged from a high of $168973.0 in Q4 2020 to a low of $168973.0 in Q4 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Gsk	93,026,132.38 Bn	93,026,127.42 Bn	7.76 Bn	3.18 Bn
2	Eli Lilly	1,022.62 Bn	1,017.34 Bn	16.22 Bn	7.23 Bn
3	Johnson & Johnson	570.65 Bn	548.59 Bn	15.96 Bn	14.11 Bn
4	AbbVie	398.73 Bn	389.38 Bn	10.78 Bn	10.54 Bn
5	Merck	295.53 Bn	289.88 Bn	12.09 Bn	19.81 Bn
6	Amgen	186.30 Bn	174.26 Bn	5.87 Bn	12.76 Bn
7	Gilead Sciences	155.93 Bn	148.21 Bn	5.52 Bn	4.55 Bn
8	Pfizer	146.09 Bn	133.32 Bn	-1.21 Bn	9.83 Bn
9	Bristol Myers Squibb	114.98 Bn	104.53 Bn	8.07 Bn	6.08 Bn
10	Scilex Holding	48.31 Mn	-101.62 Mn	4.15 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2020	168,973.00